{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:50:00Z","timestamp":1790704200887,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cld.2024.06.017","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:28:26Z","timestamp":1721827706000},"page":"831-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Anand V.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.cld.2024.06.017_bib1","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1080\/10408398.2021.1925221","article-title":"Association between alcohol intake and overweight and obesity: a systematic review and dose-response meta-analysis of 127 observational studies","volume":"62","author":"Golzarand","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2013.09.006","article-title":"The impact of obesity and metabolic syndrome on alcoholic liver disease","volume":"18","author":"Chiang","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2024.06.017_bib3","unstructured":"McPherson K. Tackling obesities: future choices\u2013modelling future trends in obesity and the impact on health 2nd Edition."},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0007114518003677","article-title":"Effect of alcohol consumption on food energy intake: a systematic review and meta-analysis","volume":"121","author":"Kwok","year":"2019","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2024.06.017_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fgstr.2022.1030399","article-title":"An update on the genetics of alcoholic liver disease","volume":"1","author":"Vishnubhotla","year":"2022","journal-title":"Frontiers in Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.10.005","article-title":"A\u00a0genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers","volume":"76","author":"Whitfield","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ajg.2015.137","article-title":"PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease","volume":"110","author":"Salameh","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"46","key":"10.1016\/j.cld.2024.06.017_bib10","doi-asserted-by":"crossref","first-page":"81321","DOI":"10.18632\/oncotarget.18466","article-title":"Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/LVT.0000000000000296","article-title":"Alcohol use disorder in alcohol-associated liver disease: two sides of the same coin","volume":"30","author":"Singal","year":"2024","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2016.08.011","article-title":"The genetics of alcohol dependence and alcohol-related liver disease","volume":"66","author":"Stickel","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.06.017_bib13","series-title":"Hepatology","article-title":"Two hit hypotheses of alcohol-associated hepatitis (AAH): the role of genes in AAH","author":"Kulkarni","year":"2023"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12072-023-10534-9","article-title":"Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future","volume":"17","author":"Xie","year":"2023","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2024.06.017_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mayocp.2021.10.026","article-title":"The mortality index for alcohol-associated hepatitis: a novel prognostic score","volume":"97","author":"Kezer","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jhep.2020.12.003","article-title":"Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality","volume":"74","author":"Abdallah","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CLD.0000000000000053","article-title":"Screening for alcohol use disorder and monitoring for alcohol use in the liver clinic","volume":"22","author":"Kulkarni","year":"2023","journal-title":"Clinical Liver Disease"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-020-00190-x","article-title":"Smartphone apps for managing alcohol consumption: a literature review","volume":"15","author":"Colbert","year":"2020","journal-title":"Addiction Sci Clin Pract"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.32143","article-title":"Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.06.017_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000404","article-title":"Clinical criteria are accurate for diagnosis of severe but not moderate alcohol-associated hepatitis","author":"Verma","year":"2024","journal-title":"Hepatology Communications"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jceh.2022.07.246","article-title":"Emerging biomarkers in alcohol-associated hepatitis","volume":"13","author":"Im","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib29","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41598-022-05196-w","article-title":"A\u00a0scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cld.2024.06.017_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2019.05.008","article-title":"Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification","volume":"71","author":"Ioannou","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib32","first-page":"30","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"ACG"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/hep.31235","article-title":"Integrated treatment of alcohol use disorder in patients with alcohol-associated liver disease: an evolving story","volume":"71","author":"Lucey","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2468-1253(21)00191-6","article-title":"Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models","volume":"7","author":"DiMartini","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib36","first-page":"1404","article-title":"Integrated multidisciplinary management of alcohol-associated liver disease","volume":"11","author":"Holbeck","year":"2023","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/apt.16461","article-title":"Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics","volume":"54","author":"Singal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"Suppl 19","key":"10.1016\/j.cld.2024.06.017_bib39","first-page":"57","article-title":"Exposure to digital alcohol marketing and alcohol use: a systematic review","volume":"19","author":"Noel","year":"2020","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib40","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/hep.32016","article-title":"Impact of public health policies on alcohol-associated liver disease in Latin America: an ecological multinational study","volume":"74","author":"Diaz","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib42","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib44","doi-asserted-by":"crossref","first-page":"e0371","DOI":"10.1097\/HC9.0000000000000371","article-title":"Granulocyte-monocyte\/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: a pilot study","volume":"8","author":"Kasuga","year":"2024","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib45","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2022.07.006","article-title":"Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF","volume":"77","author":"Engelmann","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.14309\/ajg.0000000000002275","article-title":"Safety, pharmacokinetics, and efficacy signals of larsucosterol (DUR-928) in alcohol-associated hepatitis","volume":"119","author":"Hassanein","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term outcomes of stool transplant in alcohol-associated hepatitis-analysis of clinical outcomes, relapse, gut microbiota and comparisons with standard care","volume":"12","author":"Philips","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.06.017_bib50","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib51","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A\u00a0randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib52","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jceh.2023.06.012","article-title":"Role of prophylactic antibiotics in patients with severe alcohol-related hepatitis","volume":"13","author":"Kulkarni","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib53","doi-asserted-by":"crossref","first-page":"e00306","DOI":"10.14309\/ctg.0000000000000306","article-title":"No effect in alcoholic hepatitis of gut-selective, broad-spectrum antibiotics on bacterial translocation or hepatic and systemic inflammation","volume":"12","author":"St\u00f8y","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.14309\/ajg.0000000000001611","article-title":"Primary norfloxacin prophylaxis for APASL-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial","volume":"117","author":"Kulkarni","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib55","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/liv.15207","article-title":"Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: a pilot study (RIFA-AH)","volume":"42","author":"Jim\u00e9nez","year":"2022","journal-title":"Liver Int"},{"issue":"18","key":"10.1016\/j.cld.2024.06.017_bib56","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/jama.2023.4902","article-title":"Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial","volume":"329","author":"Louvet","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cld.2024.06.017_bib57","doi-asserted-by":"crossref","first-page":"e0264278","DOI":"10.1371\/journal.pone.0264278","article-title":"The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: a randomized clinical trial","volume":"17","author":"Kimer","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2468-1253(23)00010-9","article-title":"Rifaximin-\u03b1 for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.06.017_bib59","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/jgh.15400","article-title":"Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: an open-label randomized controlled trial","volume":"36","author":"Kulkarni","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jceh.2021.07.010","article-title":"Low volume plasma exchange and low dose steroid improve survival in patients with alcohol-related acute on chronic liver failure and severe alcoholic hepatitis - preliminary experience","volume":"12","author":"Kumar","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s12072-023-10548-3","article-title":"Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure","volume":"17","author":"Kulkarni","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2024.06.017_bib62","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jceh.2023.07.382","article-title":"Standard volume plasma exchange is safe and effective for patients with severe alcohol-related hepatitis","volume":"13","author":"Vora","year":"2023","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.017_bib63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/lt.25448","article-title":"Underestimation of liver transplantation for alcoholic hepatitis in the national transplant database","volume":"25","author":"Lee","year":"2019","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib64","doi-asserted-by":"crossref","first-page":"101098","DOI":"10.1016\/j.aohep.2023.101098","article-title":"Early living donor liver transplantation for alcohol-associated hepatitis","volume":"28","author":"Kulkarni","year":"2023","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib65","first-page":"e119","article-title":"Simultaneous management of alcohol use disorder and liver disease: a systematic review and meta-analysis","volume":"17","author":"Elfeki","year":"2023","journal-title":"J\u00a0Addict Med"},{"issue":"2","key":"10.1016\/j.cld.2024.06.017_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.alcohol.2008.12.007","article-title":"RNA interference against aldehyde dehydrogenase-2: development of tools for alcohol research","volume":"43","author":"Cort\u00ednez","year":"2009","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.017_bib67","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00438-018-1420-y","article-title":"A\u00a0comparison of CRISPR\/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines","volume":"293","author":"Wang","year":"2018","journal-title":"Mol Genet Genomics"},{"issue":"30","key":"10.1016\/j.cld.2024.06.017_bib68","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.2174\/1381612827666210203142539","article-title":"Targeting epigenetic mechanisms to treat alcohol use disorders (AUD)","volume":"27","author":"Rodriguez","year":"2021","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.cld.2024.06.017_bib69","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.1000050","article-title":"The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption","volume":"6","author":"Brooks","year":"2009","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.cld.2024.06.017_bib70","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/s41386-021-01117-z","article-title":"Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study","volume":"46","author":"Palzes","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.cld.2024.06.017_bib71","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/mp.2017.97","article-title":"A\u00a0relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans","volume":"23","author":"Aoun","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.cld.2024.06.017_bib72","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.28530","article-title":"Alcoholic hepatitis: translational approaches to develop targeted therapies","volume":"64","author":"Mandrekar","year":"2016","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cld.2024.06.017_bib73","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.06.017_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.01.031","article-title":"Randomized-controlled trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis","author":"Gawrieh","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.22373","article-title":"The need for better clinical trials","volume":"48","author":"Kamath","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.017_bib76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2020.08.009","article-title":"Endpoints and design of clinical trials in patients with decompensated cirrhosis: position paper of the LiverHope Consortium","volume":"74","author":"Sola","year":"2021","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T03:47:16Z","timestamp":1729050436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1089326124000655"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.017","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}